Efficacy and limitations of natural killer cell depletion in cyclophosphamide-induced tolerance

Surg Today. 2007;37(1):24-9. doi: 10.1007/s00595-006-3329-z. Epub 2007 Jan 1.

Abstract

Purpose: We previously developed a cyclophosphamide (CP)-induced tolerance protocol, consisting of an intravenous injection of 1 x 10(8) donor spleen cells (SC) given on day 0 and an intraperitoneal injection of 200 mg/kg CP given on day 2. In the present study, we modified this protocol with natural killer cell (NK) depletion in recipient mice, and evaluated the efficacy of tolerance induction.

Methods: We used B10.D2 (H-2d; IE+) and B10 (H-2b; IE-) mice as both donors and recipients. The recipient mice were treated with donor SC, CP, and donor bone marrow cells (BMCs) with or without NK depletion.

Results: A higher level of mixed chimerism was achieved in the NK-depleted recipients. Survival of both the skin and heart donor grafts was significantly prolonged in the NK-depleted recipients. Donor reactive Vbeta11+ T cells were found at the same level as in untreated control mice. Pretreatment with recipient NK cell depletion was effective in inducing higher levels of donor mixed chimerism; however, permanent engraftment of donor bone marrow was not achieved.

Conclusion: Survival of donor grafts was remarkably prolonged in the NK cell-depleted group, but transplantation tolerance could not be induced. Our results suggest that NK cell depletion in CP-induced tolerance conditioning has some effect on the induction of donor-specific tolerance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal
  • Antigens, Surface / immunology
  • Chimerism*
  • Cyclophosphamide / immunology*
  • Heart Transplantation / immunology
  • Immune Tolerance / immunology*
  • Immunosuppressive Agents / immunology*
  • Killer Cells, Natural / immunology*
  • Lectins, C-Type / immunology
  • Mice
  • Mice, Inbred Strains
  • Models, Animal
  • NK Cell Lectin-Like Receptor Subfamily B
  • Skin Transplantation / immunology
  • Transplantation Immunology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antigens, Surface
  • Immunosuppressive Agents
  • Lectins, C-Type
  • NK Cell Lectin-Like Receptor Subfamily B
  • Cyclophosphamide